UCFIW
CN Healthy Food Tech Group Corp.
Price Chart
No historical data available
Latest Quote
$0.09
+0.00 (+0.00%)
Current Price
| Previous Close | $0.09 |
| Open | $0.14 |
| Day High | $0.09 |
| Day Low | $0.09 |
| Volume | 147,751 |
Stock Information
| Total Debt | $4.02M |
| Cash Equivalents | $29.69M |
| Revenue | $28.76M |
| Net Income | $7.33M |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Sales | $28.76M |
| Income | $7.33M |
| Book/sh | $0.34 |
Financial Ratios
| Quick Ratio | 1.56 |
| Current Ratio | 1.65 |
| Debt/Eq | 20.18 |
Returns & Margins
| ROE | 47.73% |
| Gross Margin | 71.00% |
| Operating Margin | 12.53% |
| Profit Margin | 25.48% |
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 0.26 |
Analyst Data
| Recommendation | none |
Technical Indicators
| Shares Float | 4.55M |
| Volatility | -0.30 |
Performance History
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
No history data available. Data will be fetched automatically.
About CN Healthy Food Tech Group Corp.
CN Healthy Food Tech Group Corp., together with its subsidiaries, engages in the research and development, production, and sale of bio-health food in the People's Republic of China. It operates through two segments, Wholesale Distribution and Live-Stream Sales. The company offers cordyceps peptide selenium powders, Baofei granule extract plant drinks, Yancui peptide selenium powders, Ganoderma lucidum and matsutake peptide selenium powders, ginseng peptide selenium powders, collagen peptide prebiotic drinks, plant essential oils, and Shangshangyi congee products. It sells its products through e-commerce and social platforms; and offline dealers. CN Healthy Food Tech Group Corp. was founded in 2024 and is based in Zhuhai, the People's Republic of China.
đ° Latest News
No news articles available at the moment. Check back later for updates on UCFIW.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $9,343,452 | $3,803,068 | $0 |
| Cost Of Revenue | $9,343,452 | $3,803,068 | $0 |
| Total Revenue | $27,759,850 | $11,346,907 | $0 |
| Operating Revenue | $27,759,850 | $11,346,907 | $0 |
| Expenses | |||
| Total Expenses | $15,981,411 | $5,805,006 | $0 |
| Other Income Expense | $68,099 | $13,645 | - |
| Other Non Operating Income Expenses | $68,099 | $13,645 | - |
| Net Non Operating Interest Income Expense | $473,592 | $53,491 | $0 |
| Operating Expense | $6,637,959 | $2,001,938 | $0 |
| Selling And Marketing Expense | $2,240,443 | $981,599 | $0 |
| General And Administrative Expense | $4,264,256 | $1,013,368 | - |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $8,412,519 | $3,996,003 | $0 |
| Net Interest Income | $473,592 | $53,491 | $0 |
| Interest Income | $473,592 | $53,491 | $0 |
| Normalized Income | $8,412,519 | $3,996,003 | $0 |
| Net Income From Continuing And Discontinued Operation | $8,412,519 | $3,996,003 | $0 |
| Total Operating Income As Reported | $11,778,439 | $5,541,901 | $0 |
| Net Income Common Stockholders | $8,412,519 | $3,996,003 | $0 |
| Net Income | $8,412,519 | $3,996,003 | $0 |
| Net Income Including Noncontrolling Interests | $8,412,519 | $3,996,003 | $0 |
| Net Income Continuous Operations | $8,412,519 | $3,996,003 | $0 |
| Pretax Income | $12,320,130 | $5,609,037 | $0 |
| Interest Income Non Operating | $473,592 | $53,491 | $0 |
| Operating Income | $11,778,439 | $5,541,901 | $0 |
| Gross Profit | $18,416,398 | $7,543,839 | $0 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $12,391,972 | $5,736,503 | $0 |
| Reconciled Depreciation | $613,533 | $194,602 | - |
| EBITDA (Bullshit earnings) | $12,391,972 | $5,736,503 | $0 |
| EBIT | $11,778,439 | $5,541,901 | $0 |
| Diluted NI Availto Com Stockholders | $8,412,519 | $3,996,003 | $0 |
| Tax Provision | $3,907,611 | $1,613,034 | $0 |
| Research And Development | $133,260 | $6,971 | $0 |
| Selling General And Administration | $6,504,699 | $1,994,967 | $0 |
| Other Gand A | $4,264,256 | $1,013,368 | - |
Fetched: 2026-06-09
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $17,165,337 | $8,115,411 | $1 |
| Total Assets | $44,728,600 | $50,752,737 | $15 |
| Total Non Current Assets | $7,836,840 | $6,735,029 | $0 |
| Other Non Current Assets | $161,104 | - | - |
| Goodwill And Other Intangible Assets | $2,708,844 | $2,695,177 | $0 |
| Other Intangible Assets | $2,708,844 | $2,695,177 | - |
| Current Assets | $36,891,760 | $44,017,708 | $15 |
| Other Current Assets | $2,142,564 | $19,615 | - |
| Prepaid Assets | $778,753 | $1,313,695 | $0 |
| Inventory | $956,407 | $1,250,701 | $0 |
| Receivables | $287 | $845 | $0 |
| Accounts Receivable | $287 | $845 | $0 |
| Cash Cash Equivalents And Short Term Investments | $33,013,749 | $41,432,852 | $15 |
| Cash And Cash Equivalents | $33,013,749 | $41,432,852 | $15 |
| Other Receivables | - | $19,615 | - |
| Debt | |||
| Total Debt | $3,952,849 | $0 | - |
| Long Term Debt And Capital Lease Obligation | $243,490 | $0 | - |
| Current Debt And Capital Lease Obligation | $3,709,359 | - | - |
| Current Debt | $3,473,190 | - | - |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $24,854,419 | $39,942,149 | $14 |
| Total Non Current Liabilities Net Minority Interest | $243,490 | $0 | $0 |
| Current Liabilities | $24,610,929 | $39,942,149 | $14 |
| Other Current Liabilities | $11,584 | - | - |
| Current Deferred Liabilities | $17,601,292 | $37,721,923 | $0 |
| Current Notes Payable | $3,473,190 | $0 | - |
| Payables And Accrued Expenses | $3,288,694 | $2,220,226 | $14 |
| Payables | $1,739,749 | $1,992,500 | $14 |
| Total Tax Payable | $1,670,643 | $1,407,196 | $0 |
| Income Tax Payable | $1,339,698 | $849,174 | $0 |
| Accounts Payable | $69,106 | $585,304 | $0 |
| Other Payable | - | - | $14 |
| Equity | |||
| Common Stock Equity | $19,874,181 | $10,810,588 | $1 |
| Total Equity Gross Minority Interest | $19,874,181 | $10,810,588 | $1 |
| Stockholders Equity | $19,874,181 | $10,810,588 | $1 |
| Gains Losses Not Affecting Retained Earnings | $637,245 | $-120,722 | $0 |
| Retained Earnings | $12,408,522 | $3,996,003 | $0 |
| Other | |||
| Ordinary Shares Number | $52,234,983 | $51,235,000 | $51,235,000 |
| Share Issued | $52,234,983 | $51,235,000 | $51,235,000 |
| Tangible Book Value | $17,165,337 | $8,115,411 | $1 |
| Invested Capital | $23,347,371 | $10,810,588 | $1 |
| Working Capital | $12,280,831 | $4,075,559 | $1 |
| Capital Lease Obligations | $479,659 | $0 | - |
| Total Capitalization | $19,874,181 | $10,810,588 | $1 |
| Additional Paid In Capital | $6,823,190 | $6,930,538 | $0 |
| Capital Stock | $5,224 | $4,769 | $1 |
| Common Stock | $5,224 | $4,769 | $1 |
| Long Term Capital Lease Obligation | $243,490 | $0 | - |
| Current Deferred Revenue | $17,601,292 | $37,721,923 | $0 |
| Current Capital Lease Obligation | $236,169 | $0 | - |
| Current Accrued Expenses | $1,548,945 | $227,726 | - |
| Net PPE | $4,966,892 | $4,039,852 | $0 |
| Accumulated Depreciation | $-417,009 | $-115,125 | $0 |
| Gross PPE | $5,383,901 | $4,154,977 | $0 |
| Leases | $414,708 | $0 | - |
| Other Properties | $636,965 | $1,784 | - |
| Buildings And Improvements | $4,332,228 | $4,153,193 | $0 |
| Properties | $0 | $0 | $0 |
Fetched: 2026-06-09
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-9,797,753 | $42,063,997 | $14 |
| Operating Activities | |||
| Operating Cash Flow | $-9,044,499 | $42,116,405 | $14 |
| Cash Flow From Continuing Operating Activities | $-9,044,499 | $42,116,405 | $14 |
| Operating Gains Losses | $1,621 | - | - |
| Investing Activities | |||
| Capital Expenditure | $-753,254 | $-52,408 | - |
| Investing Cash Flow | $-892,352 | $-52,408 | $0 |
| Cash Flow From Continuing Investing Activities | $-892,352 | $-52,408 | $0 |
| Financing Activities | |||
| Financing Cash Flow | $2,762 | $0 | $1 |
| Cash Flow From Continuing Financing Activities | $2,762 | $0 | $1 |
| Net Other Financing Charges | $1,016,762 | - | - |
| Issuance Of Capital Stock | - | $0 | $1 |
| Net Common Stock Issuance | - | $0 | $1 |
| Common Stock Issuance | - | $0 | $1 |
| Other | |||
| Repayment Of Debt | $-1,014,000 | $0 | - |
| Interest Paid Supplemental Data | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $3,467,815 | $108,722 | $0 |
| End Cash Position | $33,013,749 | $41,432,852 | $15 |
| Beginning Cash Position | $41,432,852 | $15 | $0 |
| Effect Of Exchange Rate Changes | $1,514,986 | $-631,160 | $0 |
| Changes In Cash | $-9,934,089 | $42,063,997 | $15 |
| Net Issuance Payments Of Debt | $-1,014,000 | $0 | - |
| Net Short Term Debt Issuance | $-1,014,000 | $0 | - |
| Short Term Debt Payments | $-1,014,000 | $0 | - |
| Net Investment Purchase And Sale | $-139,098 | $0 | - |
| Purchase Of Investment | $-139,098 | $0 | - |
| Net Intangibles Purchase And Sale | $-42,618 | $-50,597 | $0 |
| Purchase Of Intangibles | $-42,618 | $-50,597 | $0 |
| Net PPE Purchase And Sale | $-710,636 | $-1,811 | $0 |
| Purchase Of PPE | $-710,636 | $-1,811 | $0 |
| Change In Working Capital | $-20,231,316 | $37,804,577 | $14 |
| Change In Other Working Capital | $-21,166,734 | $38,295,995 | - |
| Change In Other Current Liabilities | $-27,465 | $0 | - |
| Change In Other Current Assets | $-17,686 | $0 | - |
| Change In Payables And Accrued Expense | $-463,664 | $2,254,013 | $14 |
| Change In Accrued Expense | $-164,458 | $797,705 | $0 |
| Change In Payable | $-299,206 | $1,456,308 | $14 |
| Change In Account Payable | $-591,947 | $594,211 | $0 |
| Change In Tax Payable | $292,741 | $862,097 | $0 |
| Change In Income Tax Payable | $292,741 | $862,097 | $0 |
| Change In Prepaid Assets | $1,218,822 | $-1,353,615 | $0 |
| Change In Inventory | $224,832 | $-1,390,958 | $0 |
| Change In Receivables | $579 | $-858 | $0 |
| Changes In Account Receivables | $579 | $-858 | $0 |
| Other Non Cash Items | $2,045,000 | - | - |
| Provisionand Write Offof Assets | $114,144 | $121,223 | $0 |
| Depreciation Amortization Depletion | $613,533 | $194,602 | - |
| Depreciation And Amortization | $613,533 | $194,602 | - |
| Depreciation | $613,533 | $194,602 | - |
| Gain Loss On Sale Of PPE | $1,621 | $0 | - |
| Net Income From Continuing Operations | $8,412,519 | $3,996,003 | $0 |
| Amortization Cash Flow | - | $77,725 | - |
| Amortization Of Intangibles | - | $77,725 | - |
Fetched: 2026-06-09